Literature DB >> 2785121

Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody.

A K Khanna1, D R Buskirk, R C Williams, A Gibofsky, M K Crow, A Menon, M Fotino, H M Reid, T Poon-King, P Rubinstein.   

Abstract

Numerous investigators have suspected that there is a genetic predisposition to rheumatic fever (RF). In this context we have recently produced a series of monoclonal antibodies directed against B cells obtained from RF patients one of which, labeled D8/17, identifies a B cell antigen present in 100% of all RF patients studied. While the highest percentage of positive cells were exhibited by RF probands (33.5% +/- SE), the percentage of cells in unaffected siblings and parents was 14.6 and 13%, respectively. The percentage of positive cells in APSGN probands, unaffected siblings, and parents was 2.96, 3.86, and 2.8%, respectively. A low level of B cells (5-7%) bearing the D8/17 marker was seen in control patients. The segregation pattern of the phenotypes defined by the percentage of D8/17 positive cells within HLA-typed RF families are consistent with an autosomal recessive mode of inheritance not associated with the human MHC system. We postulate that these phenotypes indicate the presence of at least one necessary genetic factor for susceptibility to RF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785121      PMCID: PMC303880          DOI: 10.1172/JCI114071

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Activated B lymphocytes: stimulators of an augmented autologous mixed leukocyte reaction.

Authors:  M K Crow; H G Kunkel
Journal:  Cell Immunol       Date:  1985-02       Impact factor: 4.868

2.  Rheumatic fever: a model for the pathological consequences of microbial-host mimicry.

Authors:  J B Zabriskie
Journal:  Clin Exp Rheumatol       Date:  1986 Jan-Mar       Impact factor: 4.473

3.  A study of HL-A antigen phenotype in rheumatic fever and rheumatic heart disease patients.

Authors:  J A Falk; J L Fleischman; J B Zabriskie; R E Falk
Journal:  Tissue Antigens       Date:  1973

4.  Association of a B-cell alloantigen with susceptibility to rheumatic fever.

Authors:  M E Patarroyo; R J Winchester; A Vejerano; A Gibofsky; F Chalem; J B Zabriskie; H G Kunkel
Journal:  Nature       Date:  1979-03-08       Impact factor: 49.962

5.  HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans.

Authors:  K Hirayama; S Matsushita; I Kikuchi; M Iuchi; N Ohta; T Sasazuki
Journal:  Nature       Date:  1987 Jun 4-10       Impact factor: 49.962

6.  HLA antigens and acute rheumatic fever: evidence for a recessive susceptibility gene linked to HLA.

Authors:  M Hafez; A Chakravarti; F el-Shennawy; Z el-Morsi; S H el-Sallab; Y Al-Tonbary
Journal:  Genet Epidemiol       Date:  1985       Impact factor: 2.135

7.  Resurgence of acute rheumatic fever in the intermountain area of the United States.

Authors:  L G Veasy; S E Wiedmeier; G S Orsmond; H D Ruttenberg; M M Boucek; S J Roth; V F Tait; J A Thompson; J A Daly; E L Kaplan
Journal:  N Engl J Med       Date:  1987-02-19       Impact factor: 91.245

8.  Rheumatic fever-associated B cell alloantigens as identified by monoclonal antibodies.

Authors:  J B Zabriskie; D Lavenchy; R C Williams; S M Fu; C A Yeadon; M Fotino; D G Braun
Journal:  Arthritis Rheum       Date:  1985-09

9.  HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors.

Authors:  M I Anastasiou-Nana; J L Anderson; J F Carlquist; J N Nanas
Journal:  Am Heart J       Date:  1986-11       Impact factor: 4.749

10.  Association of class II human histocompatibility leukocyte antigens with rheumatic fever.

Authors:  E M Ayoub; D J Barrett; N K Maclaren; J P Krischer
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

View more
  20 in total

1.  Distribution of cells bearing B-cell alloantigen(s) in North Indian rheumatic fever/rheumatic heart disease patients.

Authors:  D Kumar; P Kaul; A Grover; N K Ganguly
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

2.  Immunogenic and Genetic Factors in Rheumatic Fever.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.725

3.  Poststreptococcal arthritis.

Authors: 
Journal:  Can J Infect Dis       Date:  1995-05

4.  Rheumatic fever: changes in its incidence and presentation.

Authors:  T Vyse
Journal:  BMJ       Date:  1991-03-02

Review 5.  Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunity.

Authors:  Soumya D Chakravarty; John B Zabriskie; Allan Gibofsky
Journal:  Clin Rheumatol       Date:  2014-06-04       Impact factor: 2.980

6.  Rheumatic chorea in northern Australia: a clinical and epidemiological study.

Authors:  J R Carapetis; B J Currie
Journal:  Arch Dis Child       Date:  1999-04       Impact factor: 3.791

Review 7.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

8.  D8/17 and CD19 expression on lymphocytes of patients with acute rheumatic fever and Tourette's disorder.

Authors:  Julie L Weisz; William M McMahon; Jill C Moore; Nancy H Augustine; John F Bohnsack; James F Bale; Michael B Johnson; Jubel F Morgan; Jenise Jensen; Lloyd Y Tani; L George Veasy; Harry R Hill
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

9.  HLA and rheumatic fever in Turkish Children.

Authors:  H E Khosroshahi; O Kahramanyol; L Doğanci
Journal:  Pediatr Cardiol       Date:  1992-10       Impact factor: 1.655

10.  Rheumatic Fever and post-group a streptococcal arthritis in children.

Authors:  Judith Barash
Journal:  Curr Infect Dis Rep       Date:  2013-06       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.